Unlike the majority of previous AQUA studies in a number of different tumour types, which incorporate cytokeratin in the tumour mask [22], the current study used pan-cadherin antibodies as many RCC are cytokeratin negative [29]. The gene discussed is CDH17; the disease is renal cell carcinoma.